




Searching News Database: Guardian
HSMN NewsFeed - 26 May 2021
Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen
Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen
HSMN NewsFeed - 21 Jan 2021
Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.
Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.
HSMN NewsFeed - 31 Oct 2018
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
HSMN NewsFeed - 13 Oct 2017
Olympus Announces Continued Expansion of Its GI Endoscopic Device Line with ESD Innovations
Olympus Announces Continued Expansion of Its GI Endoscopic Device Line with ESD Innovations
HSMN NewsFeed - 15 Aug 2017
Philips announces agreement with Lakeland Health for advanced monitoring to improve patient safety
Philips announces agreement with Lakeland Health for advanced monitoring to improve patient safety
HSMN NewsFeed - 23 Jan 2016
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
HSMN NewsFeed - 4 Jan 2016
United-Guardian Receives FDA Approval to Market New Single-Dose Form of Renacidin(R)
United-Guardian Receives FDA Approval to Market New Single-Dose Form of Renacidin(R)
HSMN NewsFeed - 5 Oct 2015
Egalet Appoints Mark Strobeck, Ph.D. to Executive Vice President and Chief Operating Officer
Egalet Appoints Mark Strobeck, Ph.D. to Executive Vice President and Chief Operating Officer
HSMN NewsFeed - 29 Oct 2014
Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug
Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug
HSMN NewsFeed - 18 Jun 2014
Lakewood-Amedex Raises $5.5 Million In Series C Preferred Stock Financing
Lakewood-Amedex Raises $5.5 Million In Series C Preferred Stock Financing
HSMN NewsFeed - 28 Apr 2014
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
HSMN NewsFeed - 20 Dec 2013
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
HSMN NewsFeed - 21 Oct 2013
Bayer's CONTOUR(R) NEXT LINK Cleared For Use With Medtronic's New MiniMed(R) 530G With Enlite(R)
Bayer's CONTOUR(R) NEXT LINK Cleared For Use With Medtronic's New MiniMed(R) 530G With Enlite(R)
HSMN NewsFeed - 9 Oct 2013
Preventice, Inc. Receives CE Mark for BodyGuardian Remote Monitoring System
Preventice, Inc. Receives CE Mark for BodyGuardian Remote Monitoring System
HSMN NewsFeed - 17 Dec 2012
Angel Medical Systems, Inc. Completes Initial Closing of $27.5 Million Financing
Angel Medical Systems, Inc. Completes Initial Closing of $27.5 Million Financing
HSMN NewsFeed - 11 Apr 2011
Medtronic Launches More Accurate and Comfortable Sensor to Help Improve Glucose Control
Medtronic Launches More Accurate and Comfortable Sensor to Help Improve Glucose Control
HSMN NewsFeed - 27 Jan 2011
Vascular Solutions Acquires Zerusa Limited and the Guardian(R) Hemostasis Valves
Vascular Solutions Acquires Zerusa Limited and the Guardian(R) Hemostasis Valves
HSMN NewsFeed - 8 Sep 2008
Major Study Reinforces the Power of Medtronic Device for Better Diabetes Management
Major Study Reinforces the Power of Medtronic Device for Better Diabetes Management
HSMN NewsFeed - 30 Jun 2008
Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
HSMN NewsFeed - 23 Jun 2008
NanoGuardian Client Receives FDA Approval for Its Nanoencryption Technology
NanoGuardian Client Receives FDA Approval for Its Nanoencryption Technology
HSMN NewsFeed - 18 Jun 2008
Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
HSMN NewsFeed - 28 Apr 2008
Medtronic Announces FDA Clearance of New OneTouch(R) UltraLink(TM) Blood Glucose Meter
Medtronic Announces FDA Clearance of New OneTouch(R) UltraLink(TM) Blood Glucose Meter
HSMN NewsFeed - 24 Mar 2008
Medtronic Announces Sales Milestone of One Million Continuous Glucose Monitoring Sensors Worldwide
Medtronic Announces Sales Milestone of One Million Continuous Glucose Monitoring Sensors Worldwide
HSMN NewsFeed - 27 Nov 2007
Introgen's ADVEXIN Advances as Marketing Authorization Application is Accepted for Review in Europe
Introgen's ADVEXIN Advances as Marketing Authorization Application is Accepted for Review in Europe
HSMN NewsFeed - 27 Nov 2007
Gendux Announces Acceptance of Its ADVEXIN Marketing Authorization Application for Review by the EMEA
Gendux Announces Acceptance of Its ADVEXIN Marketing Authorization Application for Review by the EMEA
HSMN NewsFeed - 13 Nov 2007
Introgen and Gendux Submit First Marketing Authorization Application for ADVEXIN
Introgen and Gendux Submit First Marketing Authorization Application for ADVEXIN
HSMN NewsFeed - 4 Nov 2007
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
HSMN NewsFeed - 9 Jul 2007
Zerusa Limited and Vascular Solutions Announce U.S. Distribution of Guardian Hemostasis Valve
Zerusa Limited and Vascular Solutions Announce U.S. Distribution of Guardian Hemostasis Valve
HSMN NewsFeed - 20 Jun 2007
Merck Provides Update on Status of Supplemental Biologics License Applications (sBLA) for GARDASIL(R)
Merck Provides Update on Status of Supplemental Biologics License Applications (sBLA) for GARDASIL(R)
HSMN NewsFeed - 9 May 2007
New England Journal of Medicine Publishes New Data on GARDASIL(R), Merck's Cervical Cancer Vaccine
New England Journal of Medicine Publishes New Data on GARDASIL(R), Merck's Cervical Cancer Vaccine
HSMN NewsFeed - 3 Apr 2007
Signature Mapping(TM) CAD Technology to Enhance the Performance of Breast Cancer Detection
Signature Mapping(TM) CAD Technology to Enhance the Performance of Breast Cancer Detection
HSMN NewsFeed - 22 Mar 2007
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
HSMN NewsFeed - 12 Mar 2007
FDA Approves New Medtronic Continuous Glucose Monitoring Devices for Children and Teenagers
FDA Approves New Medtronic Continuous Glucose Monitoring Devices for Children and Teenagers
HSMN NewsFeed - 13 Nov 2006
Merck Launches National Advertising Campaign for GARDASIL(R), Merck's New Cervical Cancer Vaccine
Merck Launches National Advertising Campaign for GARDASIL(R), Merck's New Cervical Cancer Vaccine
HSMN NewsFeed - 1 Nov 2006
Merck's Cervical Cancer Vaccine, GARDASIL(R), Added to the CDC Vaccines for Children Contract
Merck's Cervical Cancer Vaccine, GARDASIL(R), Added to the CDC Vaccines for Children Contract
HSMN NewsFeed - 22 Sep 2006
European Commission Approves GARDASIL(R), Merck's Cervical Cancer Vaccine
European Commission Approves GARDASIL(R), Merck's Cervical Cancer Vaccine
HSMN NewsFeed - 17 Jul 2006
Medtronic Receives FDA Approval for Guardian(R) REAL-Time Continuous Glucose Monitoring System
Medtronic Receives FDA Approval for Guardian(R) REAL-Time Continuous Glucose Monitoring System
HSMN NewsFeed - 9 May 2006
Gendux AB and Introgen Therapeutics File European Orphan Drug Designation for ADVEXIN
Gendux AB and Introgen Therapeutics File European Orphan Drug Designation for ADVEXIN
HSMN NewsFeed - 8 May 2006
Introgen's ADVEXIN p53 Therapy Provided to Cancer Patients With Li-Fraumeni Syndrome
Introgen's ADVEXIN p53 Therapy Provided to Cancer Patients With Li-Fraumeni Syndrome
Additional items found! 17

Members Archive contains
17 additional stories matching:
Guardian
(Password required)
Guardian
(Password required)